The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-1-(3-(4-Pentylphenyl)acryloyl)-2,3-dihydroquinolin-4(1H)-one ID: ALA4878701
PubChem CID: 164628083
Max Phase: Preclinical
Molecular Formula: C23H25NO2
Molecular Weight: 347.46
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCc1ccc(/C=C/C(=O)N2CCC(=O)c3ccccc32)cc1
Standard InChI: InChI=1S/C23H25NO2/c1-2-3-4-7-18-10-12-19(13-11-18)14-15-23(26)24-17-16-22(25)20-8-5-6-9-21(20)24/h5-6,8-15H,2-4,7,16-17H2,1H3/b15-14+
Standard InChI Key: MNHKONRNOQWVTK-CCEZHUSRSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
17.6116 -9.0388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6105 -9.8667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3221 -10.2818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0395 -9.8662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0367 -9.0352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3203 -8.6278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7505 -8.6218 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4675 -9.0299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1814 -8.6165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8985 -9.0244 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.1783 -7.7910 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.8992 -9.8485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6121 -10.2606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3284 -9.8465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6099 -8.6076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3237 -9.0187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0324 -8.6097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0327 -7.7857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3183 -7.3723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6083 -7.7878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0406 -10.2598 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.8947 -10.2809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1796 -9.8655 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4638 -10.2798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7487 -9.8644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0330 -10.2787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 2 0
8 9 1 0
9 10 1 0
9 11 2 0
10 12 1 0
10 15 1 0
12 13 1 0
13 14 1 0
14 16 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
14 21 2 0
2 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 347.46Molecular Weight (Monoisotopic): 347.1885AlogP: 5.05#Rotatable Bonds: 6Polar Surface Area: 37.38Molecular Species: NEUTRALHBA: 2HBD: ┄#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 5.22CX LogD: 5.22Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.54Np Likeness Score: -0.22
References 1. Zhang H, Yu P, Lin H, Jin Z, Zhao S, Zhang Y, Xu Q, Jin H, Liu Z, Yang W, Zhang L.. (2021) The Discovery of Novel ACA Derivatives as Specific TRPM2 Inhibitors that Reduce Ischemic Injury Both In Vitro and In Vivo., 64 (7.0): [PMID:33784097 ] [10.1021/acs.jmedchem.0c02129 ]